Assessment of safety and efficacy of Telmisartan, Amlodipine and Chlorthalidone combination in stage 2 hypertension patients: A prospective observational study

Abstract

Hypertension is a common and high incidence disease over the global population. The prevalence rate was going up as time passes and many treatment options were developed to compress this condition. However, we have a lot of treatment choices, the studies were going still on the effectiveness and suitability issues of antihypertensive drug regimens. This study aimed to assess the safety and efficacy of the triple-drug combination (Telmisartan, Amlodipine, Chlorthalidone) therapy regimen in stage 2 hypertensive patients and so that the obtained results provide a novel treatment or fixed dosage for hypertensive management. The resulting therapy will significantly maintain the BP levels to tolerate the patient's condition.